<DOC>
	<DOCNO>NCT02929459</DOCNO>
	<brief_summary>The purpose trial investigate comprehensively effect riboflavin supplementation abundance F. prausnitzii member gut microbiota faeces healthy volunteer . Additionally assess whether riboflavin supplementation affect abundance potentially pathogenic bacteria adherent invasive E. coli ( AIEC ) . Finally , effect riboflavin supplementation production Short Chain Fatty Acids , release gut hormones potential change glucose homeostasis appetite perception assess .</brief_summary>
	<brief_title>Effects Riboflavin Faecalibacterium Prausnitzii Gut Microbiota</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Males Females , age 20 60 year Participant willing stick his/her normal habitual diet exclude consumption unusual high energyrich fatrich meal prolong fasting , etc . throughout study period Participant willing maintain his/her habitual physical activity pattern throughout study period Participant stable bodyweight within last 6 month Participant health condition would prevent him/her fulfil study requirement judge investigator basis medical history routine laboratory test result Participant body mass index ( BMI ) ≥18.5 ≤ 24.9 kg/m2 screen Participant willing refrain consume alcoholic drink 24 h prior test day ( V2 V3 ) Participant smoke Participant able motivate comply protocol requirement like instance take investigational product way prescribed test Participant understand study procedure sign form provide informed consent participate study Participant abnormal clinical chemistry haematology laboratory test result clinical significance judgment investigator would interfere participant 's ability comply study protocol ( might confound interpretation study result ) , put participant undue risk Participants history GI disorder likely interfere mode action test product Participant donate 300 mL blood three month prior screen Participant history , judgment investigator , psychological illness condition interfere participant 's ability understand requirement study Use antibiotic sign active systemic infection last 6 month Participants hypocaloric/hypercaloric diet aim weight loss/gain Participant history presence cancer prior two year , except nonmelanoma skin cancer Participant pregnant , plan pregnant study period , lactate , woman childbearing potential unwilling commit use medically approve form contraception throughout study period . The method contraception must record source documentation Regular use dietary supplement e.g . riboflavin , fish oil , 1 month prior study inclusion Participant exposure nonregistered drug product within 30 day prior screen visit Recent history ( within 12 month screen visit ) strong potential alcohol substance abuse . Alcohol abuse define &gt; 60g ( men ) / 40g ( woman ) pure alcohol per day ( 1.5 l / 1 l beer resp . 0.75 l / 0.5 l wine ) Participant know allergy sensitivity study product ingredient study product meal provide Use commercially available probiotic , prebiotic supplement may affect gut microbiota</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Gut Microbiota</keyword>
	<keyword>Riboflavin</keyword>
	<keyword>Vitamin B2</keyword>
	<keyword>oGTT</keyword>
	<keyword>Faecalibacterium prausnitzii</keyword>
</DOC>